applying for approval
Scope
Date
~
-
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...
Apr 23, 2024 (Gmt+09:00)
-
Construction
Samsung C&T to build Korea’s first $103 mn hydrogen tank for power plant
Samsung C&T Corp., the construction and trading unit of South Korea’s Samsung Group, has clinched a 140 billion won ($103 million) deal to...
Apr 09, 2024 (Gmt+09:00)
-
Corporate restructuring
Hanwha Aerospace to spin off non-core units to focus on defense business
Hanwha Aerospace Co., South Korea’s answer to Elon Musk’s SpaceX, is spinning off its non-core units to focus on defense and aerospace b...
Apr 03, 2024 (Gmt+09:00)
-
Chemical Industry
Lotte Chemical applies recycled plastic to packaging
South Korea's Lotte Chemical announced on Thursday that it has applied recycled materials to all 25 kg packaging bags for polyethylene (PE) and poly...
Mar 28, 2024 (Gmt+09:00)
-
Entertainment
K Enter moves step closer to Nasdaq listing in May
K Enter Holdings Inc., an umbrella entity of South Korea-based entertainment companies creating original entertainment content and managing related ...
Mar 27, 2024 (Gmt+09:00)
-
Artificial intelligence
Lunit gets court approval for Volpara acquisition in New Zealand
South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to a...
Mar 14, 2024 (Gmt+09:00)
-
Automobiles
Hyundai Mobis applies 1,200 future mobility patents in 2023
Hyundai Mobis has strengthened its competitiveness in future mobility by filing numerous patents in the electric and autonomous driving fields.The c...
Mar 04, 2024 (Gmt+09:00)
-
Logistics
Samsung SDS gets CEIV Pharma certification
South Korea's Samsung SDS Co. said on Wednesday that it has achieved the Center of Excellence for Independent Validators in Pharmaceutical Logistics...
Feb 21, 2024 (Gmt+09:00)
-
Artificial intelligence
LG Elec, Upstage to form partnership for on-device AI
South Korea’s artificial intelligence startup Upstage said on Tuesday it has signed a memorandum of understanding with LG Electronics Inc. to ...
Feb 06, 2024 (Gmt+09:00)
-
Energy
Hanwha Q Cells to unveil Q.TRON G2 solar module
Hanwha Q Cells Co., a solar power unit of South Korean conglomerate Hanwha Group, announced on Monday that it will unveil its new solar module ser...
Feb 06, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Cloud computing
Naver Cloud launches real-time streaming feature
South Korea's Naver Cloud, the cloud computing arm of Naver Corp., announced on Friday that it has launched a "real-time streaming" feature for "CLO...
Feb 02, 2024 (Gmt+09:00)
-
Airlines
Japan approves Korean Air-Asiana merger
Japan has finally given the nod to the merger between South Korea’s No. 1 full-service carrier Korean Air Lines Co. and No. 2 Asiana Airlines ...
Jan 31, 2024 (Gmt+09:00)
-
Banking & Finance
S.Korea’s LS Group wins regulatory nod for securities biz
South Korea’s electrics components-to-energy conglomerate LS Group is set to start the securities business as it secured regulatory approval t...
Jan 18, 2024 (Gmt+09:00)
-
Corporate restructuring
Taeyoung becomes 1st Korean builder in debt workout in decade
The vast majority of creditors to Taeyoung Engineering & Construction Co. (Taeyoung E&C) have agreed to start debt restructuring for the tro...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
CGBio gets FDA approval for Novosis Putty
South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...
Jan 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
J&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio gets approval for cancer diagnostic device in Thailand
South Korean medical diagnostic company NGeneBio Co. announced on Friday that it has received approval for the sale of its in-vitro diagnostic medic...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
ToolGen gets FDA approval for TGT-001 as ODD
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
Dec 18, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets FDA approval for Alyglo
South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...
Dec 18, 2023 (Gmt+09:00)
-
Private equity
China's CICC enters S.Korea with its private equity fund
BEIJING – CICC Capital, a unit of China International Capital Corp. (CICC), has entered the South Korean market with the launch of a private e...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm gears up to boost epilepsy drug sales in Europe
SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...
Nov 16, 2023 (Gmt+09:00)
-
Batteries
SK Ecoplant develops core battery recycling technologies
South Korea’s SK Ecoplant Co. has developed four core battery-recycling technologies, including recovering nickel and cobalt from spent lithiu...
Nov 14, 2023 (Gmt+09:00)
-
Artificial intelligence
Lunit gets FDA approval for AI cancer diagnosis solution
South Korean medical AI company Lunit said on Tuesday its Lunit Insight DBT, an AI imaging diagnosis solution aiding in breast cancer diagnosis, has...
Nov 14, 2023 (Gmt+09:00)
-
Corporate restructuring
SK Energy to spin off tank terminal business as new logistics firm
SK Energy Co., a unit of South Korean oil refiner and battery maker SK Innovation Co., is spinning off its crude oil storage and shipment business t...
Nov 13, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Amorepacific's camellia-derived cosmetic ingredients get COSMOS
South Korean cosmetics giant Amorepacific Corp. said on Thursday its camellia-derived cosmetic ingredients got COSMetic Organic and natural Standard...
Nov 10, 2023 (Gmt+09:00)